Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on April 25, 2025
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
GlobeNewswire
·
April 25, 2025
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29 Zug, Switzerland, April 25, 2025 – MoonLake Immunotherapeutics (Nasdaq: MLTX), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory …
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
GlobeNewswire
·
April 25, 2025
SALT LAKE CITY, April 25, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced new clinical data will be shared at the American Association for Cancer Research (AACR) …
Prelude Announces Presentations at 2025 AACR Annual Meeting
GlobeNewswire
·
April 25, 2025
Preclinical data elucidating the mechanism of action of PRT3789, Prelude’s first-in-class, highly selective SMARCA2 degrader currently in early clinical development Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, …
AEON Biopharma Announces NYSE American Acceptance of Plan to Regain Listing Compliance
GlobeNewswire
·
April 25, 2025
IRVINE, Calif., April 25, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (“AEON” or the “Company”) (NYSE: AEON), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex for the treatment of multiple therapeutic indications …
Digital Ally, Inc. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Annual Report on Form 10-K
GlobeNewswire
·
April 25, 2025
Lenexa, KS, April 25, 2025 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (Nasdaq: DGLY) (the “Company”) today announced it received a delinquency notification letter from Nasdaq on April 23, 2025, which indicated that the Company was not in compliance with Nasdaq …
Molecular Partners presents new preclinical data on Radio-DARPin and Switch-DARPin programs at AACR 2025
GlobeNewswire
·
April 25, 2025
Positive IND-enabling data on MP0712 targeting DLL3, the most advanced Radio-DARPin program in co-development with Orano Med, entering clinical development in 2025 First preclinical data of novel targeted Radio-DARPin against mesothelin (MSLN), in co- …
Spanios and White Lion Capital LLC Announce Strategic Partnership to Accelerate Drug Development
GlobeNewswire
·
April 25, 2025
HOUSTON, April 25, 2025 (GLOBE NEWSWIRE) -- Spanios, a leader in human-derived organoid model systems, is pleased to announce a strategic partnership with White Lion Capital LLC. This collaboration empowers biotech and pharma companies to leverage Spanios’ …
Clenbuterol Bodybuilding (Clen) Pills, Clenbuterol Dosage, Clenbuterol, Benefits, Clenbuterol Side Effects, Clenbuterol Cycles, Where to buy Clenbuterol tablet buy, ambroxol, lavizoo (CrazyBulk)
GlobeNewswire
·
April 25, 2025
New York City, April 25, 2025 (GLOBE NEWSWIRE) -- Why Do People Look for Weight Loss Pills? Many people want a leaner body and look for pills to help them achieve this. One such pill is Clenbuterol, which is often used for weight loss. However, Clenbuterol …
Discovery Announces Management Appointments
GlobeNewswire
·
April 25, 2025
TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) is pleased to announce the following management appointments: Pierre Rocque as Chief Operating Officer; Jennifer Wagner as Executive …
Pangu Launches Otherworlds.ai, a Fully On-Chain Web3 Strategy Game Powered by AI
GlobeNewswire
·
April 25, 2025
Singapore, April 25, 2025 (GLOBE NEWSWIRE) -- Developer Pangu has released Otherworlds.ai, a lightweight, AI-powered strategy game that is optimized for instant browser play and offers complete on-chain transparency. This follows the success of MetaCene, …
Best Probiotics For Women: Top-Rated Picks for Digestion, Mood, and Immunity Announced By WhatBest.
GlobeNewswire
·
April 25, 2025
New York, April 25, 2025 (GLOBE NEWSWIRE) -- WhatBest, a leading authority known for meticulous, research-based evaluations of health and wellness products, is excited to announce its comprehensive list of the best probiotics specifically chosen for women. …
Tevogen Bio Announces 2025 Annual Meeting
GlobeNewswire
·
April 25, 2025
WARREN, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen Bio” or “Company”) (Nasdaq: TVGN) today announced that the Company will hold its 2025 annual meeting of stockholders (the “Annual Meeting”) via live webcast at 11 a.m. …
NETRIS Pharma Announces Positive Interim Phase II Results for NP137 in combination with anti-PD(L)1
EIN Presswire
·
April 25, 2025
Confirmation of NP137 Potential to Overcome Resistance to Immune Checkpoint - Clinical Trial Design and Interim Results to be Presented at ASCO and ESMO 2025 LYON, FRANCE, April 25, 2025 /EINPresswire.com/ -- NETRIS Pharma, a clinical-stage private …
Introducing the ELECFREAKS micro:bit Nezha Pro Sports Kit: Bringing Robotics to Life Through Play
EIN Presswire
·
April 25, 2025
ELECFREAKS Nezha Pro Sports Kit: Build …
HPQ Silicium : Correction de communiqués antérieurs
GlobeNewswire
·
April 25, 2025
En réponse à une demande formulée par l’Autorité des marchés financiers, HPQ Silicium procède à la publication d’un communiqué rectificatif visant à corriger certaines informations à caractère prospectif diffusées dans des communiqués antérieurs. MONTRÉAL, …
Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC
GlobeNewswire
·
April 25, 2025
Gene signatures associated with increased efficacy of micvotabart pelidotin (MICVO) due to greater linker cleavage were identified based on differential gene expression analysis of PDX responders/non-responders Mouse analog of MICVO in a syngeneic model …
H2Ocean Showcases Healing Innovation at ASPO 2025, Empowering Cancer Survivors Through Science
EIN Presswire
·
April 25, 2025
At the American Society of Preventive Oncology’s 49th Annual Meeting, H2Ocean’s Healing Rinse garners praise for tackling chemo mouth with sea salt science. STUART, FL, UNITED STATES, April 25, 2025 /EINPresswire.com/ -- H2Ocean, the pioneer of sea salt …
Starton Therapeutics Presents Positive Data from Phase 1b Study Evaluating STAR-LLD for the Treatment of Relapsed/Refractory Multiple Myeloma at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
PARAMUS, N.J., April 25, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary dermal technologies, announced today the presentation of positive data …
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
GlobeNewswire
·
April 25, 2025
- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus rituximab and lenalidomide (R2) was well-tolerated and demonstrated promising anti-tumor activity - Combination …
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
GlobeNewswire
·
April 25, 2025
– TK-6302, a supercharged PRAME targeting TCR-T therapy, demonstrates best-in-class preclinical anti-tumor efficacy as compared to current clinical stage PRAME TCR-T approaches, providing the potential for broad, deep and durable responses in hard-to-treat …